Biotech News
Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib
ir.reparerx.com2026-05-06 15:28 EST
CAMBRIDGE, Mass. & MONTREAL --(BUSINESS WIRE)--Jul. 15, 2025-- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced it has entered into an exclusive worldwide licensing agreement with Debiopharm International S.A.